Evidence map›Paper›PMID 30071869›Full record

ArticleCritical care (London, England)2018

Erythrocyte P2X

Steen K Fagerberg, Parth Patel, Lars W Andersen, Xiaowen Lui, Michael W Donnino, Helle A Praetorius

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. P2XPurinergic signalling · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Steen K FagerbergDepartment of Biomedicine, Physiology, Aarhus University, Ole Worms Alle 3, build 1170, 8000, Aarhus C, Denmark.
Parth PatelDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Lars W AndersenDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Xiaowen LuiDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Michael W DonninoDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Helle A PraetoriusDepartment of Biomedicine, Physiology, Aarhus University, Ole Worms Alle 3, build 1170, 8000, Aarhus C, Denmark. hp@biomed.au.dk.ORCID 0000-0002-0970-5061
Beth Israel Deaconess Medical Center · USAarhus University · DK

Funding

Sundhed og Sygdom, Det Frie Forskningsråd DFF-1331-00203A
6 · The paper itself

Abstract

backgroundPore-forming proteins released from bacteria or formed as result of complement activation are known to produce severe cell damage. Inhibition of purinergic P2X receptors markedly reduces damage inflicted by cytolytic bacterial toxin and after complement activation in both erythrocytes and monocytes. P2X expression generally shows variation throughout the population. Here, we investigate correlation between P2X receptor abundance in blood cell plasma membranes and haematocrit during sepsis, in patients admitted to the emergency department (ED) or intensive care unit (ICU).

methodPatients admitted to the ED and successively transferred to ICU with the diagnosis sepsis (< 2 systemic inflammatory response syndrome (SIRS) criteria and suspected infection), were grouped as either blood pathogen-positive (14 patients) or blood pathogen-negative (20 patients). Blood samples drawn at ICU admission were analysed for P2X

resultsHere, we find inverse correlation between P2X

conclusionHigh levels of P2X

Indexed as

AgedBacterial ToxinsEmergency Service, HospitalEnzyme-Linked Immunosorbent AssayFemaleGram-Negative BacteriaGram-Positive BacteriaHematocritHumansIntensive Care UnitsMaleMiddle AgedProspective StudiesReceptors, Purinergic P2X1SepsisSystemic Inflammatory Response SyndromeBacterial ToxinsReceptors, Purinergic P2X1Vitamin DAnaemiaExotoxemia/endotoxemiaHaematocritHaemoglobinHaemolysisP2XPurinergic signallingSepsisToxins

Identifiers

PMID30071869
PMCPMC6091015
OpenAlexW2886943027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.